370 related articles for article (PubMed ID: 6954481)
21. Phenylbutyrate therapy for maple syrup urine disease.
Brunetti-Pierri N; Lanpher B; Erez A; Ananieva EA; Islam M; Marini JC; Sun Q; Yu C; Hegde M; Li J; Wynn RM; Chuang DT; Hutson S; Lee B
Hum Mol Genet; 2011 Feb; 20(4):631-40. PubMed ID: 21098507
[TBL] [Abstract][Full Text] [Related]
22. Comparative metabolism and structure of BCKD-E2 in primary biliary cirrhosis.
Turchany JM; Leung PS; Iwayama T; Jefferson DM; Ishida J; Yamaguchi M; Munoz S; Danner DJ; Dickson ER; Gershwin ME
J Autoimmun; 1993 Aug; 6(4):459-66. PubMed ID: 8216688
[TBL] [Abstract][Full Text] [Related]
23. Impaired assembly of E1 decarboxylase of the branched-chain alpha-ketoacid dehydrogenase complex in type IA maple syrup urine disease.
Wynn RM; Davie JR; Chuang JL; Cote CD; Chuang DT
J Biol Chem; 1998 May; 273(21):13110-8. PubMed ID: 9582350
[TBL] [Abstract][Full Text] [Related]
24. Lessons from genetic disorders of branched-chain amino acid metabolism.
Chuang DT; Chuang JL; Wynn RM
J Nutr; 2006 Jan; 136(1 Suppl):243S-9S. PubMed ID: 16365091
[TBL] [Abstract][Full Text] [Related]
25. Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients.
Chuang JL; Davie JR; Chinsky JM; Wynn RM; Cox RP; Chuang DT
J Clin Invest; 1995 Mar; 95(3):954-63. PubMed ID: 7883996
[TBL] [Abstract][Full Text] [Related]
26. Thiamine response in maple syrup urine disease.
Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
[TBL] [Abstract][Full Text] [Related]
27. [Gene analysis of maple syrup urine disease (MSUD)].
Mitsubuchi H; Nobukuni Y; Hayashida Y; Ohta K; Indo Y; Akaboshi I; Endo F; Matsuda I
Rinsho Byori; 1993 May; 41(5):484-91. PubMed ID: 8350511
[TBL] [Abstract][Full Text] [Related]
28. Sequence of the E1 alpha subunit of branched-chain alpha-ketoacid dehydrogenase in two patients with thiamine-responsive maple syrup urine disease.
Zhang B; Wappner RS; Brandt IK; Harris RA; Crabb DW
Am J Hum Genet; 1990 Apr; 46(4):843-6. PubMed ID: 2316528
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease.
AEvarsson A; Chuang JL; Wynn RM; Turley S; Chuang DT; Hol WG
Structure; 2000 Mar; 8(3):277-91. PubMed ID: 10745006
[TBL] [Abstract][Full Text] [Related]
30. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
[TBL] [Abstract][Full Text] [Related]
31. Occurrence of a Tyr393----Asn (Y393N) mutation in the E1 alpha gene of the branched-chain alpha-keto acid dehydrogenase complex in maple syrup urine disease patients from a Mennonite population.
Fisher CR; Fisher CW; Chuang DT; Cox RP
Am J Hum Genet; 1991 Aug; 49(2):429-34. PubMed ID: 1867199
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of mutations in maple syrup urine disease (MSUD): screening and identification of affected E1 alpha and E1 beta subunits of the branched-chain alpha-keto-acid dehydrogenase multienzyme complex.
Nobukuni Y; Mitsubuchi H; Hayashida Y; Ohta K; Indo Y; Ichiba Y; Endo F; Matsuda I
Biochim Biophys Acta; 1993 Nov; 1225(1):64-70. PubMed ID: 8161368
[TBL] [Abstract][Full Text] [Related]
33. Oral L-alloisoleucine loading studies in healthy subjects and in patients with maple syrup urine disease.
Schadewaldt P; Dalle-Feste C; Langenbeck U; Wendel U
Pediatr Res; 1991 Nov; 30(5):430-4. PubMed ID: 1754297
[TBL] [Abstract][Full Text] [Related]
34. E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.
Chuang JL; Cox RP; Chuang DT
J Clin Invest; 1997 Aug; 100(3):736-44. PubMed ID: 9239422
[TBL] [Abstract][Full Text] [Related]
35. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
[TBL] [Abstract][Full Text] [Related]
36. Production and characterization of murine models of classic and intermediate maple syrup urine disease.
Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS
BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849
[TBL] [Abstract][Full Text] [Related]
37. [Maple syrup urine disease: molecular pathology of the branched chain alpha-keto acid dehydrogenase complex].
Nobukuni Y; Mitsubuchi H; Indo Y; Endo F; Matsuda I
Seikagaku; 1992 Feb; 64(2):67-82. PubMed ID: 1593184
[No Abstract] [Full Text] [Related]
38. In vivo and in vitro response of human branched chain alpha-ketoacid dehydrogenase to thiamine and thiamine pyrophosphate.
Danner DJ; Wheeler FB; Lemmon SK; Elsas LJ
Pediatr Res; 1978 Mar; 12(3):235-8. PubMed ID: 643394
[No Abstract] [Full Text] [Related]
39. Evidence that the branched-chain alpha-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral cortex.
Funchal C; Gottfried C; De Almeida LM; Wajner M; Pessoa-Pureur R
Glia; 2004 Nov; 48(3):230-40. PubMed ID: 15390119
[TBL] [Abstract][Full Text] [Related]
40. A nonsense mutation (R242X) in the branched-chain alpha-keto acid dehydrogenase E1alpha subunit gene (BCKDHA) as a cause of maple syrup urine disease. Mutations in brief no. 160. Online.
Chinsky J; Appel M; Almashanu S; Costeas P; Ambulos N; Carmi R
Hum Mutat; 1998; 12(2):136. PubMed ID: 10694918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
